$RGEN
REPLIGEN CORP

2018 Q2 Form 10-Q Financial Statement

#000119312518236196 Filed on August 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $47.73M $32.46M
YoY Change 47.07% 11.26%
Cost Of Revenue $21.09M $13.94M
YoY Change 51.31% 10.23%
Gross Profit $26.64M $18.52M
YoY Change 43.88% 12.05%
Gross Profit Margin 55.82% 57.06%
Selling, General & Admin $16.59M $11.19M
YoY Change 48.32% 37.41%
% of Gross Profit 62.27% 60.4%
Research & Development $5.780M $1.860M
YoY Change 210.75% -1.59%
% of Gross Profit 21.69% 10.04%
Depreciation & Amortization $3.930M $1.700M
YoY Change 131.18% 28.79%
% of Gross Profit 14.75% 9.18%
Operating Expenses $43.46M $26.98M
YoY Change 61.06% 169.01%
Operating Profit $4.273M $5.473M
YoY Change -21.93% -6.59%
Interest Expense $1.669M $1.601M
YoY Change 4.25% 150.94%
% of Operating Profit 39.06% 29.25%
Other Income/Expense, Net $251.0K -$328.0K
YoY Change -176.52% -537.33%
Pretax Income $3.367M $3.654M
YoY Change -7.85% -31.98%
Income Tax $629.0K -$4.784M
% Of Pretax Income 18.68% -130.93%
Net Earnings $2.738M $8.438M
YoY Change -67.55% 117.92%
Net Earnings / Revenue 5.74% 26.0%
Basic Earnings Per Share $0.06 $0.25
Diluted Earnings Per Share $0.06 $0.24
COMMON SHARES
Basic Shares Outstanding 43.74M shares 34.10M shares
Diluted Shares Outstanding 45.02M shares 35.09M shares

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $175.6M $145.0M
YoY Change 21.1% -20.24%
Cash & Equivalents $175.6M $142.2M
Short-Term Investments $2.700M
Other Short-Term Assets $4.600M $2.300M
YoY Change 100.0% 76.92%
Inventory $40.95M $26.09M
Prepaid Expenses
Receivables $31.71M $22.12M
Other Receivables $0.00 $500.0K
Total Short-Term Assets $252.9M $195.9M
YoY Change 29.07% -10.09%
LONG-TERM ASSETS
Property, Plant & Equipment $23.99M $16.00M
YoY Change 49.99% 16.7%
Goodwill $327.1M $60.98M
YoY Change 436.41% 96.54%
Intangibles $139.2M $29.01M
YoY Change 379.72% 51.22%
Long-Term Investments
YoY Change
Other Assets $1.902M $6.380M
YoY Change -70.19% 1176.0%
Total Long-Term Assets $492.2M $112.8M
YoY Change 336.25% 75.27%
TOTAL ASSETS
Total Short-Term Assets $252.9M $195.9M
Total Long-Term Assets $492.2M $112.8M
Total Assets $745.1M $308.8M
YoY Change 141.31% 9.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.688M $6.951M
YoY Change -3.78% -9.59%
Accrued Expenses $13.10M $9.568M
YoY Change 36.94% -29.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $101.3M
YoY Change
Total Short-Term Liabilities $121.1M $16.52M
YoY Change 633.21% -22.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $97.20M
YoY Change -100.0% 4.07%
Other Long-Term Liabilities $4.660M $1.616M
YoY Change 188.37% -13.95%
Total Long-Term Liabilities $4.660M $1.616M
YoY Change 188.37% -13.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $121.1M $16.52M
Total Long-Term Liabilities $4.660M $1.616M
Total Liabilities $125.8M $18.14M
YoY Change 593.57% -21.93%
SHAREHOLDERS EQUITY
Retained Earnings -$26.00M -$48.36M
YoY Change -46.23% -26.79%
Common Stock $635.8M $248.0M
YoY Change 156.4% 3.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $598.7M $190.9M
YoY Change
Total Liabilities & Shareholders Equity $745.1M $308.8M
YoY Change 141.31% 9.37%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income $2.738M $8.438M
YoY Change -67.55% 117.92%
Depreciation, Depletion And Amortization $3.930M $1.700M
YoY Change 131.18% 28.79%
Cash From Operating Activities $5.970M $2.810M
YoY Change 112.46% -73.39%
INVESTING ACTIVITIES
Capital Expenditures -$2.850M -$1.380M
YoY Change 106.52% 40.82%
Acquisitions
YoY Change
Other Investing Activities $0.00 $9.440M
YoY Change -100.0% -4820.0%
Cash From Investing Activities -$2.850M $8.050M
YoY Change -135.4% -782.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.150M 160.0K
YoY Change 618.75% -99.86%
NET CHANGE
Cash From Operating Activities 5.970M 2.810M
Cash From Investing Activities -2.850M 8.050M
Cash From Financing Activities 1.150M 160.0K
Net Change In Cash 4.270M 11.02M
YoY Change -61.25% -90.88%
FREE CASH FLOW
Cash From Operating Activities $5.970M $2.810M
Capital Expenditures -$2.850M -$1.380M
Free Cash Flow $8.820M $4.190M
YoY Change 110.5% -63.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43805802 shares
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142657000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6688000
CY2018Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
674000
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11143000
CY2018Q2 us-gaap Assets
Assets
745081000
CY2018Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
937000
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
61000
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13102000
CY2018Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
372000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
252909000
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31713000
CY2018Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
403000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25724000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
635364000
CY2018Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
764000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175611000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175611000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43798572 shares
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43798572 shares
CY2018Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
157440000
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
438000
CY2018Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4532000
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
101329000
CY2018Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
20643000
CY2018Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1175000
CY2018Q2 us-gaap Deferred Revenue
DeferredRevenue
1175000
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
30256000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7703000
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18258000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9365000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
9363000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9866000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
10456000
CY2018Q2 us-gaap Goodwill
Goodwill
327095000
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
139182000
CY2018Q2 us-gaap Inventory Net
InventoryNet
40948000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5284000
CY2018Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4429000
CY2018Q2 us-gaap Land
Land
1023000
CY2018Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12613000
CY2018Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
23946000
CY2018Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4389000
CY2018Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
15770000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
745081000
CY2018Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
121119000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3257000
CY2018Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
0
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3567000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1902000
CY2018Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
23199000
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1838000
CY2018Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
0
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4660000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3643000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2050000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1817000
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4620000
CY2018Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
17000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6363000
CY2017Q4 us-gaap Assets
Assets
743519000
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1668000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
58000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17929000
CY2017Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1383000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23993000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2933301 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
20854000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1008777 shares
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26000000
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49717000
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12502000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
26.37
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
21518000
CY2018Q2 us-gaap Share Price
SharePrice
47.04
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
448068 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
19.14
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1058834 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.72
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
598659000
CY2018Q2 rgen Operating Lease Future Minimum Payments Due In Four Years And Thereafter
OperatingLeaseFutureMinimumPaymentsDueInFourYearsAndThereafter
4872000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122683000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7282000
CY2017Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1191000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
242782000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27585000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
947000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23800000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
628983000
CY2017Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
764000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173759000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173759000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43587079 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43587079 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
436000
CY2017Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2581000
CY2017Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
99250000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
25167000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
960000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9560000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13331000
CY2017Q4 us-gaap Goodwill
Goodwill
327333000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
144753000
CY2017Q4 us-gaap Inventory Net
InventoryNet
39004000
CY2017Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4272000
CY2017Q4 us-gaap Land
Land
1023000
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
158084000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12570000
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22351000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4083000
CY2017Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
15673000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
743519000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25211000
CY2017Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
0
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6234000
CY2017Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
21904000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2220000
CY2017Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
0
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2343000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2281000
CY2017Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
153000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22417000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31508000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46217000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
734940 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.80
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
591548000
CY2018Q2 rgen Lease Agreement Area
LeaseAgreementArea
40000 sqft
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1484000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1956000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
222001 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19974000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16584000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27926000
us-gaap Costs And Expenses
CostsAndExpenses
51895000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5384000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3278000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.490 pure
us-gaap Depreciation
Depreciation
1858000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2053000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2150000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-86000
us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
0 shares
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-64000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
754000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7721000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3785000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1740000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-226000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
236000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
286991 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6347000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4216000
us-gaap Interest Expense
InterestExpense
3187000
us-gaap Investment Income Net
InvestmentIncomeNet
206000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
813000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
433483 shares
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14132000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5073000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-172000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3961000
us-gaap Net Income Loss
NetIncomeLoss
11506000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-448000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2676000
us-gaap Operating Income Loss
OperatingIncomeLoss
11150000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
16850000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1505000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
1677000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
42000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20367000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.94
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
63045000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3602000
us-gaap Share Based Compensation
ShareBasedCompensation
3027000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1734000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34715797 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33995323 shares
rgen Payment Of Contingent Consideration In Common Stock
PaymentOfContingentConsiderationInCommonStock
1062000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5298000
dei Amendment Flag
AmendmentFlag
false
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2089000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
615930 shares
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> <b>1. Basis of Presentation</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The condensed consolidated financial statements included herein have been prepared by Repligen Corporation (the &#x201C;Company&#x201D;, &#x201C;Repligen&#x201D; or &#x201C;we&#x201D;) in accordance with generally accepted accounting principles in the United States (&#x201C;U.S. GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;), for Quarterly Reports on Form&#xA0;<font style="WHITE-SPACE: nowrap">10-Q</font>&#xA0;and Article 10 of Regulation&#xA0;<font style="WHITE-SPACE: nowrap">S-X</font>&#xA0;and do not include all of the information and footnote disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company&#x2019;s Annual Report on Form&#xA0;<font style="WHITE-SPACE: nowrap">10-K</font>&#xA0;for the fiscal year ended December&#xA0;31, 2017.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Repligen Sweden AB (&#x201C;Repligen Sweden&#x201D;), Repligen GmbH, Repligen Singapore Pte. Ltd., our former subsidiary, TangenX Technology Corporation (&#x201C;TangenX,&#x201D; acquired on December&#xA0;14, 2016 and merged into the Company as of June&#xA0;30, 2017) and Spectrum LifeSciences, LLC (&#x201C;Spectrum,&#x201D; acquired on August&#xA0;1, 2017). All significant intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> <i>Recently Issued Accounting Pronouncements</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In May 2014, the FASB issued ASU&#xA0;<font style="WHITE-SPACE: nowrap">No.&#xA0;2014-09,</font>&#xA0;&#x201C;Revenue from Contracts with Customers (Topic 606),&#x201D;<i>&#xA0;</i>(&#x201C;ASC 606&#x201D;) which supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605,&#xA0;<i>Revenue Recognition</i>, and creates a new Topic 606,&#xA0;<i>Revenue from Contracts with Customers</i>. Two adoption methods are permitted: retrospectively to all prior reporting periods presented, with certain practical expedients permitted; or retrospectively with the cumulative effect of initially adopting the ASU recognized at the date of initial application. The adoption of this ASU included updates as provided under ASU&#xA0;<font style="WHITE-SPACE: nowrap">2015-14,</font>&#xA0;&#x201C;Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date&#x201D;;&#xA0;ASU&#xA0;<font style="WHITE-SPACE: nowrap">2016-08,</font>&#xA0;&#x201C;Revenue from Contracts with Customers (Topic&#xA0;606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)&#x201D;; ASU&#xA0;<font style="WHITE-SPACE: nowrap">2016-10,</font>&#xA0;&#x201C;Revenue from Contracts with Customers (Topic&#xA0;606): Identifying Performance Obligations and Licensing&#x201D;; and ASU&#xA0;<font style="WHITE-SPACE: nowrap">2016-12,</font>&#xA0;&#x201C;Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&#x201D; The Company adopted the provisions of ASC 606 using the modified retrospective method effective January&#xA0;1, 2018. See Note 3 for further discussion of the effects of this standard on the Company&#x2019;s consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In January 2016, the FASB issued ASU&#xA0;<font style="WHITE-SPACE: nowrap">No.&#xA0;2016-01,</font>&#xA0;&#x201C;Financial Instruments&#x2014;Overall (Subtopic&#xA0;<font style="WHITE-SPACE: nowrap">825-10):</font>&#xA0;Recognition and Measurement of Financial Assets and Financial Liabilities.&#x201D; This guidance changes how entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. A practicability exception will be available for equity investments that do not have readily determinable fair values; however, the exception requires the Company to consider relevant transactions that can be&#xA0;reasonably known to identify any observable price changes that would impact the fair value. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. The Company adopted this guidance in the first quarter of 2018. Because the Company does not hold any equity securities as of December&#xA0;31, 2017 and June&#xA0;30, 2018, adoption of this standard did not have any impact on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In February 2016, the FASB issued ASU No.&#xA0;<font style="WHITE-SPACE: nowrap">2016-02,&#xA0;&#x201C;Leases</font>&#xA0;(Topic 842)&#x201D; (&#x201C;ASU&#xA0;<font style="WHITE-SPACE: nowrap">2016-02&#x201D;).</font>&#xA0;ASU&#xA0;<font style="WHITE-SPACE: nowrap">2016-02</font>&#xA0;requires lessees to recognize a&#xA0;<font style="WHITE-SPACE: nowrap"><font style="WHITE-SPACE: nowrap">right-of-use</font></font>&#xA0;asset and a lease liability for most leases. Extensive quantitative and qualitative disclosures, including significant judgments made by management, will be required to provide greater insight into the extent of revenue and expense recognized and expected to be recognized from existing contracts. The accounting applied by a lessor is largely unchanged from that applied under the current standard. The standard provides for certain practical expedients and must be adopted using either a modified retrospective transition approach or retrospectively with the cumulative effect of initially adopting the ASU recognized at the date of initial application. This ASU is effective for public entities for fiscal years beginning after December&#xA0;15, 2018, with early adoption permitted. The Company has commenced its review of leases as part of this standard, but has not finalized its assessment of the impact of the new standard on its consolidated financial statements. The Company expects this new standard to have a material impact on the Company&#x2019;s consolidated balance sheet.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In August 2016, the FASB issued ASU&#xA0;<font style="WHITE-SPACE: nowrap">No.&#xA0;2016-15,</font>&#xA0;&#x201C;Statement of Cash Flows (Topic 203): Classification of Certain Cash Receipts and Cash Payments&#x201D;. ASU&#xA0;<font style="WHITE-SPACE: nowrap">No.&#xA0;2016-15</font>&#xA0;addresses eight specific cash flow issues and clarifies their presentation and classification in the Statement of Cash Flows. This ASU is effective for fiscal years beginning after December&#xA0;15, 2017 and is to be applied retrospectively with early adoption permitted. The Company has historically classified payments up to the amount of its contingent consideration liability recognized at the date of its acquisition as financing activities, with additional payments classified as operating activities. Because the Company has classified its contingent consideration payments as required by this standard, the adoption of this standard did not have any impact on its consolidated financial statements when applied on a retrospective basis.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In October 2016, the FASB issued ASU&#xA0;<font style="WHITE-SPACE: nowrap">2016-16,&#xA0;&#x201C;Intra-Entity</font>&#xA0;Transfers of Assets Other Than Inventory.&#x201D;&#xA0;ASU&#xA0;<font style="WHITE-SPACE: nowrap">2016-16</font>&#xA0;requires that the income tax consequences of an intra-entity asset transfer other than inventory are recognized at the time of the transfer. An entity will continue to recognize the income tax consequences of an intercompany transfer of inventory when the inventory is sold to a third party. The Company adopted this standard on a modified-retrospective basis on January&#xA0;1, 2018. See Note 12 for a discussion of the impact of this ASU on the Company&#x2019;s financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In November 2016, the FASB issued ASU&#xA0;<font style="WHITE-SPACE: nowrap">No.&#xA0;2016-18,</font>&#xA0;&#x201C;Statement of Cash Flows (Topic 230): Restricted Cash,&#x201D; which requires that the statement of cash flows explain the change during the period in the total cash, which is inclusive of cash and cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Restricted cash and restricted cash equivalents will be included with cash and cash equivalents when reconciling the beginning of period and end of period balances on the statement of cash flows upon adoption of this standard. The Company adopted this standard on a retrospective basis on January&#xA0;1, 2018. The adoption resulted in an increase to cash, cash equivalents and restricted cash of $450,000 in the statement of cash flows at December&#xA0;31, 2016 and June&#xA0;30, 2017. The Company did not hold any restricted cash at December&#xA0;31, 2017 or June&#xA0;30, 2018.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In January 2017, the FASB issued ASU&#xA0;No.&#xA0;<font style="WHITE-SPACE: nowrap">2017-01,&#xA0;&#x201C;Business</font>&#xA0;Combinations (Topic 805): Clarifying the Definition of a Business&#x201D;, which clarifies the definition of a business to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The Company adopted this standard as of January&#xA0;1, 2018, and the adoption of ASU&#xA0;<font style="WHITE-SPACE: nowrap">2017-01</font>&#xA0;did not have a material impact on the Company&#x2019;s consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In January 2017, the FASB issued ASU&#xA0;<font style="WHITE-SPACE: nowrap">No.&#xA0;2017-04,</font>&#xA0;&#x201C;Intangibles&#x2013;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#x201D; eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. ASU&#xA0;<font style="WHITE-SPACE: nowrap">No.&#xA0;2017-04</font>&#xA0;requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January&#xA0;1, 2020, with early adoption permitted. The Company adopted this standard as of January&#xA0;1, 2018, and the adoption of this standard did not have a material impact on the Company&#x2019;s consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In February 2018, the FASB issued ASU&#xA0;<font style="WHITE-SPACE: nowrap">2018-02,</font>&#xA0;&#x201C;Income Statement &#x2013; Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income,&#x201D; which gives entities the option to reclassify to retained earnings tax effects related to items that have been stranded in accumulated other comprehensive income as a result of the Tax Cuts and Jobs Act (the &#x201C;Act&#x201D;). For all entities, the guidance is effective for fiscal years beginning after December&#xA0;15, 2018, and interim periods within those fiscal years. Entities can choose whether to apply the amendments retrospectively to each period in which the effect of the Act is recognized or to apply the amendments in the period of adoption. The Company has not assessed the impact of the new standard on its consolidated financial statements, but does not expect this new standard to have a material impact on the Company&#x2019;s consolidated financial statements.</p> </div>
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1852000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1405000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
40756000
us-gaap Costs And Expenses
CostsAndExpenses
82312000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
325000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7894000
dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.221 pure
us-gaap Depreciation
Depreciation
2598000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Type
DocumentType
10-Q
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y7M6D
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2750000
dei Entity Central Index Key
EntityCentralIndexKey
0000730272
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1458000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
43000
us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
0 shares
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P16Y
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1241000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7942000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1757000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-701000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-60000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
144000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
578134 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4788000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3985000
us-gaap Interest Expense
InterestExpense
3321000
us-gaap Investment Income Net
InvestmentIncomeNet
693000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3096000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
433961 shares
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4412000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4780000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1479000
us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
5609000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7535000
us-gaap Net Income Loss
NetIncomeLoss
6185000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
321000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4412000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Operating Income Loss
OperatingIncomeLoss
10249000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1490000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32488000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.41
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
11000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
92561000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9068000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
34.48
us-gaap Share Based Compensation
ShareBasedCompensation
4893000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
9588 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M25D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
29.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
429678 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y5M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1783000
dei Trading Symbol
TradingSymbol
RGEN
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
96196 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44694745 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43682650 shares
rgen Increase Decrease In Revenues
IncreaseDecreaseInRevenues
29516000
rgen Contract With Customer Liability Beginning Balance
ContractWithCustomerLiabilityBeginningBalance
751000
rgen Increase Decrease In Royalty Revenue
IncreaseDecreaseInRoyaltyRevenue
-23000
rgen Increase Decrease In Sales Revenue Goods Net
IncreaseDecreaseInSalesRevenueGoodsNet
29539000
CY2017 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P16Y
CY2017 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Expire at various dates through December 2037.
CY2017 us-gaap Tax Credit Carryforward Limitations On Use
TaxCreditCarryforwardLimitationsOnUse
Expire at various dates through December 2037.
CY2017 rgen Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
12812000
CY2017 rgen Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense
TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
3266000
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
187072 shares
rgen Impairment Loss On Receivable
ImpairmentLossOnReceivable
0
rgen Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
-1000
rgen Lease Agreement Payment Condition
LeaseAgreementPaymentCondition
Fixed rent with respect to 40,000 square feet of the Premises commenced on the Commencement Date, and rent for the full 63,761 square feet of the Premises shall begin 19 months following the Commencement Date.
rgen Option To Extend Lease Years
OptionToExtendLeaseYears
2 pure
rgen Percentage Change In Revenue
PercentageChangeInRevenue
0.468 pure
rgen Percentage Change In Royalty Revenue
PercentageChangeInRoyaltyRevenue
-0.548 pure
rgen Percentage Change In Sales Revenue Goods Net
PercentageChangeInSalesRevenueGoodsNet
0.469 pure
CY2018Q1 rgen Lease Commencement Date
LeaseCommencementDate
2018-06-01
CY2018Q1 rgen Lease Agreement Term
LeaseAgreementTerm
P126M
CY2018Q1 rgen Lease Agreement Area
LeaseAgreementArea
63761 sqft
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12484000
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13937000
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
26982000
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.309 pure
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2017Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2017Q2 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
0 shares
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3654000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4784000
CY2017Q2 us-gaap Income Tax Reconciliation Disposition Of Assets
IncomeTaxReconciliationDispositionOfAssets
-5625000
CY2017Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
559582 shares
CY2017Q2 us-gaap Interest Expense
InterestExpense
1601000
CY2017Q2 us-gaap Investment Income Net
InvestmentIncomeNet
110000
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
437427 shares
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4046000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
8438000
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-328000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5473000
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11185000
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32455000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1860000
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1496000
CY2017Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-9200000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35094814 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34097805 shares
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
551012 shares
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2293000
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21088000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
43458000
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.187 pure
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2018Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2018Q2 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
0 shares
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3367000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
629000
CY2018Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
791802 shares
CY2018Q2 us-gaap Interest Expense
InterestExpense
1669000
CY2018Q2 us-gaap Investment Income Net
InvestmentIncomeNet
512000
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
480561 shares
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5031000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
2738000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
251000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4273000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16590000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
47731000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5780000
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2625000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45015720 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43743356 shares
CY2018Q2 rgen Increase Decrease In Revenues
IncreaseDecreaseInRevenues
15276000
CY2018Q2 rgen Increase Decrease In Royalty Revenue
IncreaseDecreaseInRoyaltyRevenue
-33000
CY2018Q2 rgen Increase Decrease In Sales Revenue Goods Net
IncreaseDecreaseInSalesRevenueGoodsNet
15309000
CY2018Q2 rgen Percentage Change In Revenue
PercentageChangeInRevenue
0.471 pure
CY2018Q2 rgen Percentage Change In Royalty Revenue
PercentageChangeInRoyaltyRevenue
-1.571 pure
CY2018Q2 rgen Percentage Change In Sales Revenue Goods Net
PercentageChangeInSalesRevenueGoodsNet
0.472 pure

Files In Submission

Name View Source Status
0001193125-18-236196-index-headers.html Edgar Link pending
0001193125-18-236196-index.html Edgar Link pending
0001193125-18-236196.txt Edgar Link pending
0001193125-18-236196-xbrl.zip Edgar Link pending
d491984d10q.htm Edgar Link pending
d491984dex101.htm Edgar Link pending
d491984dex311.htm Edgar Link pending
d491984dex312.htm Edgar Link pending
d491984dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20180630.xml Edgar Link completed
rgen-20180630.xsd Edgar Link pending
rgen-20180630_cal.xml Edgar Link unprocessable
rgen-20180630_def.xml Edgar Link unprocessable
rgen-20180630_lab.xml Edgar Link unprocessable
rgen-20180630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending